| Financial Year |
March 31 2023 |
| Monetary Funds |
1,415,345,021.64 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
478,065,096.64 |
| Advances to Suppliers |
28,451,174.38 |
| Other Receivables |
28,114,449.14 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,098,546,020.76 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
38,676,698.06 |
| Total Current Assets |
3,096,868,966.09 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
219,466,941.52 |
| Investment Properties |
59,928,281.36 |
| Fixed Assetes |
806,373,201.74 |
| Under-construction Projects |
394,376,162.47 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
427,621,687.40 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
52,872,925.02 |
| Deferred Income Tax Assets |
33,934,304.97 |
| Other Non-Current Assets |
137,537,371.37 |
| Sub-Total of Non-Current Assets |
2,343,690,394.48 |
| Total Assets |
5,440,559,360.57 |
| Short-Term Loans |
68,382,400.98 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
369,630,460.45 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
27,560,537.47 |
| Taxes Payable |
44,893,255.31 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
118,160,147.87 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
32,868,597.45 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
666,295,324.71 |
| Long-term Loans |
603,481,272.23 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
268,440.07 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
717,624,789.31 |
| Total Liabilities |
1,383,920,114.02 |
| Paid-In Capital(Or Share Stock) |
265,555,583.00 |
| Capital Surplus |
3,139,387,880.59 |
| Surplus Reserve |
92,849,639.49 |
| LESS:Treasury Stock |
95,697,000.00 |
| Undistributed Profits |
672,745,724.09 |
| Minority Stockholder's Interest |
-20,651,258.02 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,077,290,504.57 |
| Owner's Equity（Stockholder's Equity） |
4,056,639,246.55 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,440,559,360.57 |
